Pfizer may sell animal health business to clear Wyeth merger
Thursday, 19 March 2009 by Rosalind Donald
Pharmaceutical company Pfizer may shed some of its veterinary drugs business to get the green light from the US Federal Trade Commission for its acquisition of rival Wyeth.
Subscription required to view this article
This content can only be accessed by GCR subscribers.
A subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current print and online content.
Please note: If you would like online access to all archived content, you will need a Premium subscription.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top